AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23788090 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with obesity and excessive physical activity
Number of subjects: 1986
Study 21793317 — intervention group
Group type: EXPERIMENTAL
Intervention: Eleutherococcus senticosus (ES) 800 mg/d
Number of subjects: 9
Study 18834621 — intervention group
Group type: EXPERIMENTAL
Intervention: p53 overexpression in GOG-157 cohort (paclitaxel+carboplatin)
Number of subjects: 279
Study 18834621 — intervention group
Group type: EXPERIMENTAL
Intervention: p53 overexpression in GOG-111 cohort (cyclophosphamide+cisplatin vs. paclitaxel+cisplatin)
Number of subjects: 279
Study 16634838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon extract (3 g of cinnamon powder per day)
Number of subjects: 79
Study 16634838 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule
Number of subjects: 79
Study 16634838 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon extract
Number of subjects: 79
Study 14671184 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (10 mg/d)
Number of subjects: 64
Study 14671184 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone (4 mg/d)
Number of subjects: 64
Study 14671184 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 11328775 — intervention group
Group type: EXPERIMENTAL
Intervention: Roxithromycin 300 mg/day
Number of subjects: 9
Study 9041573 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (0.1 mg.kg‐1, maximum 4 mg)
Number of subjects: 427
Study 7949641 — intervention group
Group type: EXPERIMENTAL
Intervention: L-thyroxine (L-T4) therapy
Number of subjects: 34
Study 7949641 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 34
Study 3281930 — intervention group
Group type: EXPERIMENTAL
Intervention: Adinazolam
Number of subjects: 72
Study 3281930 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 31669068 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% TXA mouthwash
Number of subjects: 236
Study 31669068 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 29149145 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic Epidural Laser Decompression (EELD)
Number of subjects: 97
Study 29149145 — intervention group
Group type: EXPERIMENTAL
Intervention: Transforaminal Epiduroscopic Laser Annuloplasty (TELA)
Number of subjects: 97
Study 26712288 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of Acacia nilotica paste
Number of subjects: 24
Study 26712288 — intervention group
Group type: COMPARATOR
Intervention: Topical application of povidone-iodine solution
Number of subjects: 24
Study 26712288 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall mortality rate
Number of subjects: 24
Study 23183521 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead-in telaprevir arm (4 weeks of PegIFN-α-2a and ribavirin followed by 12 weeks of telaprevir plus PegIFN-α-2a/ribavirin)
Number of subjects: 240
Study 23183521 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead-in telaprevir arm
Number of subjects: 240
Study 21788077 — intervention group
Group type: EXPERIMENTAL
Intervention: Latanoprost ophthalmic solution 0.005% administered once daily in 1 or both eyes for ≥2 weeks.
Number of subjects: 47
Study 19366977 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized feedback to patients
Number of subjects: 3703
Study 19366977 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized feedback to physicians
Number of subjects: 3703
Study 19366977 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized feedback to both patients and physicians
Number of subjects: 3703
Study 19366977 — intervention group
Group type: COMPARATOR
Intervention: No customized feedback (control group)
Number of subjects: 3703
Study 19366977 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized feedback to patients and/or physicians
Number of subjects: 3703
Study 16951643 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir (LPV/r) 800/200 mg once daily
Number of subjects: 190
Study 16951643 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r) 400/100 mg twice daily
Number of subjects: 190
Study 15560809 — intervention group
Group type: EXPERIMENTAL
Intervention: Finger brush (I‐Brush)
Number of subjects: 37
Study 15560809 — intervention group
Group type: COMPARATOR
Intervention: Manual toothbrush (Butler GUM 311)
Number of subjects: 37
Study 11738748 — intervention group
Group type: EXPERIMENTAL
Intervention: Ty21a(pDB1)
Number of subjects: 12
Study 11738748 — intervention group
Group type: COMPARATOR
Intervention: Ty21a
Number of subjects: 12
Study 9416190 — intervention group
Group type: EXPERIMENTAL
Intervention: Sterile catheterization
Number of subjects: 29
Study 9416190 — intervention group
Group type: COMPARATOR
Intervention: Nonsterile catheterization
Number of subjects: 29
Study 8352817 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine controlled-release formulation (Corinfar retard dragees)
Number of subjects: 22
Study 8352817 — intervention group
Group type: COMPARATOR
Intervention: Reference preparation
Number of subjects: 22
Study 29935905 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical drains present during surgery
Number of subjects: 0
Study 29935905 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of drainage
Number of subjects: 0
Study 29935905 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of drains used
Number of subjects: 0
Study 29935905 — intervention group
Group type: EXPERIMENTAL
Intervention: Type of drains (open versus closed)
Number of subjects: 0
Study 29935905 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical division and duration of surgery
Number of subjects: 0
Study 29935905 — intervention group
Group type: EXPERIMENTAL
Intervention: Wound class
Number of subjects: 0
Study 29935905 — intervention group
Group type: EXPERIMENTAL
Intervention: Location of drains
Number of subjects: 0
Study 30514159 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosocial behavior
Number of subjects: 102
Study 30514159 — intervention group
Group type: EXPERIMENTAL
Intervention: Antisocial behavior
Number of subjects: 102
Study 30514159 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 102
Study 27338942 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphatic Drainage (LD)
Number of subjects: 64
Study 27338942 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Massage (TM)
Number of subjects: 64
Study 27338942 — intervention group
Group type: COMPARATOR
Intervention: Waiting Group (WG)
Number of subjects: 64
Study 24548413 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel topical cream that selectively filters nontherapeutic wavelengths of UVB from natural sunlight
Number of subjects: 0
Study 24548413 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22872692 — intervention group
Group type: EXPERIMENTAL
Intervention: Leptin replacement therapy
Number of subjects: 0
Study 22872692 — intervention group
Group type: COMPARATOR
Intervention: Control (healthy individuals)
Number of subjects: 0
Study 20552794 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytoflavin
Number of subjects: 30
Study 18639791 — intervention group
Group type: EXPERIMENTAL
Intervention: Student Bodies 2 (SB2), a 16-week cognitive-behavioral program
Number of subjects: 80
Study 18639791 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 80
Study 18639791 — intervention group
Group type: EXPERIMENTAL
Intervention: Student Bodies 2 (SB2)
Number of subjects: 80
Study 15627183 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 T MRI
Number of subjects: 19
Study 15627183 — intervention group
Group type: COMPARATOR
Intervention: 1.5 T MRI
Number of subjects: 19
Study 12011682 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy
Number of subjects: 420
Study 12011682 — intervention group
Group type: COMPARATOR
Intervention: Tap/Biopsy
Number of subjects: 420
Study 12011682 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate Vitrectomy
Number of subjects: 420
Study 10078401 — intervention group
Group type: COMPARATOR
Intervention: 4 mg ondansetron i.v.
Number of subjects: 51
Study 10078401 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 4 mg ondansetron and 8 mg dexamethasone i.v.
Number of subjects: 51
Study 7735342 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 1
Study 7735342 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 7735342 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone plus psychotherapy
Number of subjects: 1
Study 7735342 — intervention group
Group type: COMPARATOR
Intervention: Psychotherapy alone
Number of subjects: 1
Study 2160758 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (60 mg/day for 6 days)
Number of subjects: 14
Study 2160758 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 2160758 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 14
Study 7382535 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (0.25 mg/kg hydralazine)
Number of subjects: 23
Study 7382535 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (0.5 mg/kg hydralazine)
Number of subjects: 23
Study 30738699 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal slow wave EEG power in UHR individuals
Number of subjects: 44
Study 30738699 — intervention group
Group type: COMPARATOR
Intervention: Frontal slow wave EEG power in UHR-P vs UHR-NP
Number of subjects: 44
Study 30738699 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal slow wave EEG power following transition to psychosis
Number of subjects: 44
Study 30738699 — intervention group
Group type: EXPERIMENTAL
Intervention: Delta frequency power correlation in UHR group
Number of subjects: 44
Study 30738699 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal delta or theta power and functioning
Number of subjects: 44
Study 29276777 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentist-provided treatments (glutaraldehyde/HEMA compounds, oxalates, bonding agents)
Number of subjects: 1862
Study 29276777 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentists' advice and counseling regarding oral habits and diet
Number of subjects: 1862
Study 29276777 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-applied fluoride toothpaste
Number of subjects: 1862
Study 25648739 — intervention group
Group type: EXPERIMENTAL
Intervention: Kefir drink
Number of subjects: 75
Study 25648739 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk
Number of subjects: 75
Study 25648739 — intervention group
Group type: COMPARATOR
Intervention: Control (low-fat dairy products, maintenance energy intake)
Number of subjects: 75
Study 24726172 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented fixation
Number of subjects: 168
Study 24726172 — intervention group
Group type: COMPARATOR
Intervention: Cementless fixation
Number of subjects: 168
Study 22293030 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe/simvastatin 10/40 mg
Number of subjects: 250
Study 22293030 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 40 mg
Number of subjects: 250
Study 21400791 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine administration in traditional subarachnoid anesthesia (SA) protocol
Number of subjects: 0
Study 21400791 — intervention group
Group type: COMPARATOR
Intervention: Traditional subarachnoid anesthesia (SA)
Number of subjects: 0
Study 21400791 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine administration in traditional SA protocol
Number of subjects: 0
Study 17591533 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (ACE-inhibitor group; 36 patients)
Number of subjects: 70
Study 17591533 — intervention group
Group type: COMPARATOR
Intervention: No therapy (control group; 34 subjects)
Number of subjects: 70
Study 15686584 — intervention group
Group type: EXPERIMENTAL
Intervention: Feelings of resource scarcity (poor or hungry)
Number of subjects: 1176
Study 15686584 — intervention group
Group type: COMPARATOR
Intervention: Feelings of abundance (rich or full)
Number of subjects: 1176
Study 12196421 — intervention group
Group type: EXPERIMENTAL
Intervention: High fiber cereal foods (19 g/day additional cereal fiber)
Number of subjects: 23
Study 12196421 — intervention group
Group type: COMPARATOR
Intervention: Low fiber supplements (4 g/day additional cereal fiber)
Number of subjects: 23
Study 9869199 — intervention group
Group type: EXPERIMENTAL
Intervention: Low IL-6 and CRP serum levels (N=21)
Number of subjects: 39
Study 9869199 — intervention group
Group type: EXPERIMENTAL
Intervention: Detectable IL-6 (N=10)
Number of subjects: 39
Study 9869199 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP <10 mg/l (N=unknown)
Number of subjects: 39
Study 9869199 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher CRP levels (N=5)
Number of subjects: 39
Study 9869199 — intervention group
Group type: EXPERIMENTAL
Intervention: Univariate analysis of CRP and IL-6 levels
Number of subjects: 39
Study 9869199 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP levels and B symptoms
Number of subjects: 39
Study 9869199 — intervention group
Group type: EXPERIMENTAL
Intervention: CRP and LDH levels
Number of subjects: 39
Study 7888983 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (C) 40 mg/day
Number of subjects: 62
Study 7888983 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 62
Study 7888983 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (C)
Number of subjects: 62
Study 2240139 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant immunotherapy with methanol-extracted residue of bacille Calmette-Guerin
Number of subjects: 113
Study 2240139 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 113
Study 2240139 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant immunotherapy
Number of subjects: 113
Study 365536 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 80 mg
Number of subjects: 23
Study 365536 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 120 mg
Number of subjects: 23
Study 365536 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 23
Study 365536 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 240 mg
Number of subjects: 23
Study 365536 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol 320 mg
Number of subjects: 23
Study 365536 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 31827366 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometric Jump Training (PJT)
Number of subjects: 26
Study 31827366 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 26
Study 29443557 — intervention group
Group type: EXPERIMENTAL
Intervention: Power Through Choices (PTC) intervention
Number of subjects: 1036
Study 27567824 — intervention group
Group type: EXPERIMENTAL
Intervention: Savvy Caregiver Program (SCP)
Number of subjects: 164
Study 27567824 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 164
Study 24484944 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional Endoscopy Sinus Surgery (ESS)
Number of subjects: 83
Study 24484944 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon Sinuplasty (BS)
Number of subjects: 83
Study 21745436 — intervention group
Group type: EXPERIMENTAL
Intervention: GSK598809 (175 mg)
Number of subjects: 26
Study 21745436 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 20559037 — intervention group
Group type: EXPERIMENTAL
Intervention: 7vPnC vaccine with CPG 7909 adjuvant
Number of subjects: 95
Study 20559037 — intervention group
Group type: COMPARATOR
Intervention: 7vPnC vaccine with placebo adjuvant
Number of subjects: 95
Study 20559037 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART-treated individuals
Number of subjects: 95
Study 20559037 — intervention group
Group type: COMPARATOR
Intervention: HAART-naive individuals
Number of subjects: 95
Study 20559037 — intervention group
Group type: EXPERIMENTAL
Intervention: HAART use
Number of subjects: 95
Study 17384858 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% chlorine dioxide mouthrinse
Number of subjects: 14
Study 17384858 — intervention group
Group type: COMPARATOR
Intervention: Placebo mouthrinse
Number of subjects: 14
Study 16544524 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy-induced hypertension (PIH)
Number of subjects: 70
Study 14574041 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation of the atrioventricular node
Number of subjects: 0
Study 14574041 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation of the atrioventricular node with permanent pacing
Number of subjects: 0
Study 14574041 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal atrial fibrillation ablation
Number of subjects: 0
Study 14574041 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation techniques for ventricular tachycardia
Number of subjects: 0
Study 10673910 — intervention group
Group type: EXPERIMENTAL
Intervention: Inulin (up to 34 g/d)
Number of subjects: 8
Study 10673910 — intervention group
Group type: COMPARATOR
Intervention: Control diet (devoid of inulin)
Number of subjects: 8
Study 8707977 — intervention group
Group type: EXPERIMENTAL
Intervention: Coe-pak
Number of subjects: 0
Study 8707977 — intervention group
Group type: COMPARATOR
Intervention: RD8
Number of subjects: 0
Study 8707977 — intervention group
Group type: EXPERIMENTAL
Intervention: Both dressings
Number of subjects: 0
Study 1518257 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ALL-BFM 81 protocol with late reinduction protocol III and therapy stopped after reinduction.
Number of subjects: 818
Study 1518257 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ALL-BFM 81 protocol with 6-MP and MTX for another six months after reinduction.
Number of subjects: 818
Study 1518257 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified ALL-BFM 86 study with reduced MTX dosage from 5 g/m2 to 1 g/m2.
Number of subjects: 818
Study 1518257 — intervention group
Group type: COMPARATOR
Intervention: Intermediate dose MTX (4 x 0.5 g/m2) in standard risk patients.
Number of subjects: 818
Study 6434415 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral nutrition
Number of subjects: 60
Study 6434415 — intervention group
Group type: COMPARATOR
Intervention: Parenteral nutrition
Number of subjects: 60
Study 30851445 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face (FTF) communication mode with prior knowledge
Number of subjects: 2
Study 30851445 — intervention group
Group type: COMPARATOR
Intervention: Computer-mediated communication (CMC) mode with prior knowledge
Number of subjects: 2
Study 30851445 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face (FTF) communication mode without prior knowledge
Number of subjects: 2
Study 30851445 — intervention group
Group type: COMPARATOR
Intervention: Computer-mediated communication (CMC) mode without prior knowledge
Number of subjects: 2
Study 28669290 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine-based collaborative care (TOP)
Number of subjects: 265
Study 28669290 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 265
Study 25505191 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal jasmine flower extract (JFE)
Number of subjects: 35
Study 25505191 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 35
Study 24274963 — intervention group
Group type: EXPERIMENTAL
Intervention: Culturally adapted CBT (CaCBT) based self-help
Number of subjects: 0
Study 24274963 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study 21079512 — intervention group
Group type: EXPERIMENTAL
Intervention: Desirudin (15 or 30 mg every 12 hours)
Number of subjects: 16
Study 21079512 — intervention group
Group type: COMPARATOR
Intervention: Argatroban (activated partial thromboplastin time-adjusted by intravenous infusion)
Number of subjects: 16
Study 21079512 — intervention group
Group type: EXPERIMENTAL
Intervention: Desirudin
Number of subjects: 16
Study 21079512 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 16
Study 21079512 — intervention group
Group type: COMPARATOR
Intervention: Argatroban
Number of subjects: 16
Study 19374294 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid, 250 mg four times a day for 5 days
Number of subjects: 100
Study 19374294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 17428479 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH antagonist
Number of subjects: 246
Study 17428479 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist
Number of subjects: 246
Study 15682779 — intervention group
Group type: EXPERIMENTAL
Intervention: Community mobilization and outreach activities
Number of subjects: 2381
Study 12605261 — intervention group
Group type: EXPERIMENTAL
Intervention: Sine Amsler Charts (SAC) preoperative testing
Number of subjects: 63
Study 12605261 — intervention group
Group type: EXPERIMENTAL
Intervention: Sine Amsler Charts (SAC) postoperative testing
Number of subjects: 63
Study 12605261 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity postoperative
Number of subjects: 63
Study 12605261 — intervention group
Group type: EXPERIMENTAL
Intervention: Decrease in SAC score with increase in visual acuity
Number of subjects: 63
Study 9435326 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin A (20 U)
Number of subjects: 30
Study 9435326 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 30
Study 8033240 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release ketoprofen (SRK) in the morning (200 mg once a day)
Number of subjects: 117
Study 8033240 — intervention group
Group type: COMPARATOR
Intervention: Sustained-release ketoprofen (SRK) in the evening (200 mg once a day)
Number of subjects: 117
Study 2755708 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled analgesia (PCA)
Number of subjects: 88
Study 2755708 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular injections on demand (i.m.)
Number of subjects: 88
Study 73694 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (self-monitoring and reinforcement)
Number of subjects: 38
Study 73694 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 31776595 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of the spot sign
Number of subjects: 57